The platform will undergo maintenance on Sep 14 at about 7:45 AM EST and will be unavailable for approximately 2 hours.
2021
DOI: 10.1093/jnci/djab096
|View full text |Cite
|
Sign up to set email alerts
|

The National Cancer Institute’s Role in Advancing Health-Care Delivery Research

Abstract: Improvements in cancer care delivery have the potential to reduce morbidity and mortality from cancer, however challenges to delivery of recommended care limit progress. These challenges include growing demands for care, increasing treatment complexity, inadequate care coordination, dramatic increases in costs, persistent disparities in care, and insufficient use of evidence-based guidelines. Recognizing the important role of research in understanding and addressing these challenges, the National Cancer Instit… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
5
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 9 publications
(5 citation statements)
references
References 21 publications
0
5
0
Order By: Relevance
“…Providing care consistent with quality indicators can be intervened on at a system (rather than clinical) level to improve survival. 49 While clinical and biological advances continue in parallel, this avenue provides the potential to impact a large amount of AYAs with ALL. NOTE.…”
Section: Discussionmentioning
confidence: 99%
“…Providing care consistent with quality indicators can be intervened on at a system (rather than clinical) level to improve survival. 49 While clinical and biological advances continue in parallel, this avenue provides the potential to impact a large amount of AYAs with ALL. NOTE.…”
Section: Discussionmentioning
confidence: 99%
“…Federal sponsors increasingly solicit research proposals requiring multilevel considerations (Jacobsen et al, 2021). Solicitations encourage investigators to consider all relevant multilevel factors potentially related to intervention implementation and effectiveness (NCI, 2017).…”
Section: Incentivizing Multilevel Researchmentioning
confidence: 99%
“…In recent decades cancer survival rates in economically developed countries have steadily improved,7–9 often resulting in years of complex treatment programmes, including surgery, radiation, immunotherapy and combined multi-drug chemotherapy with or without subsequent haematopoietic stem cell transplantation 10–12. Antineoplastic (chemotherapy) treatment continues to play a significant role, elevating the risk of symptoms and side effects such as fatigue, pain, physical deterioration, and functional and emotional decline 13–16.…”
Section: Introductionmentioning
confidence: 99%
“…[3][4][5][6] In recent decades cancer survival rates in economically developed countries have steadily improved, 7-9 often resulting in years of complex treatment programmes, including surgery, radiation, immunotherapy and combined multi-drug chemotherapy with or without subsequent haematopoietic stem cell transplantation. [10][11][12] Antineoplastic (chemotherapy) treatment continues to play a significant role, elevating the risk of symptoms and side effects such as fatigue, pain, physical deterioration, and functional and emotional decline. [13][14][15][16] Concurrently, a significant interest has increasingly taken hold in the role of exercise and supportive care following a cancer diagnosis to reduce the disruption patients with cancer experience in their lives, 17 18 especially in terms of supporting cancer survivorship through secondary and tertiary prevention since avoiding physical…”
Section: Introductionmentioning
confidence: 99%